skip to main content

BK Virus Nephropathy — SCE Infectious Diseases MCQ

Instant feedback + full explanation. One question, done properly.

HardImmunocompromised HostBK Virus NephropathySCE Infectious Diseases

Kidney-transplant surveillance shows sustained BK DNAaemia above 10,000 copies/mL and biopsy-proven BK polyomavirus nephropathy. What is the therapeutic cornerstone?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: BReduce maintenance immunosuppression in a staged manner with close viral-load and graft-function monitoring with review

The best answer is “Reduce maintenance immunosuppression in a staged manner with close viral-load and graft-function monitoring with review”. Controlled immune reconstitution is the evidence-based core treatment; no antiviral has established routine curative efficacy and graft removal is not first-line. “Start ganciclovir because BK is a herpesvirus” is less appropriate because it does not satisfy the scenario's decisive clinical or jurisdictional requirement. “Use leflunomide as proven curative monotherapy” is less appropriate because it does not satisfy the scenario's decisive clinical or jurisdictional requirement. “Give full-dose cidofovir routinely despite nephrotoxicity” is less appropriate because it does not satisfy the scenario's decisive clinical or jurisdictional requirement. “Perform immediate graft nephrectomy before modifying immunosuppression” is less appropriate because it does not satisfy the scenario's decisive clinical or jurisdictional requirement.

Reference: Second International Consensus Guidelines on BK polyomavirus: https://journals.lww.com/transplantjournal/fulltext/2024/09000/the_second_international_consensus_guidelines_on.7.aspx